Heres a quick-reference list of what not to do
Final thoughts
A team from Maccabi Health Services retrospectively analysed data on the use of semaglutide in 200,000 patients from the Maccabi diabetes registry
We do not recommend the use of Ultra-Jet, heat-based vaporizers, or any enhanced high-speed type nebulizers with this product
Future research should prioritize large, multicenter, rigorously designed RCTs with standardized outcomes, and efforts to publish both positive and negative findings are essential to establish a balanced evidence base
Similar content being viewed by others Introduction The globally rising incidence and survival of type 1 diabetes (T1D) imposes a considerable socio-economic burden driven by the associated macro- (coronary artery disease, stroke, peripheral artery disease), and microvascular (retinopathy, nephropathy, and neuropathy) complications 1,2